Vital bio systems pvt. ltd. - Company Profile

441 views

Published on

For the complete report, get in touch with us at : info@netscribes.com

Vital Bio Systems is headquartered in Chennai and manufactures Medical Equipments such as Infusion Pumps, Syringe Pumps, Pulse Oximeters, Telemedicine Module, Multipara Monitors, Compatible Oxymetry Probes, O2 Sensors, Slim Manager, Sakura - CSSD Equipments, Finapres, SunTech Medicals, Fisher & Paykel Healthcare, Osteometer Meditech Inc. Vital Bios Systems consists of two companies, Vital Instrumentation (P) Ltd. and Vital Bio Systems (P) Ltd.

The report begins with the basic facts about the company such as contact details, revenues, competitors, brief history, line of business and geographic reach among others. Key Products and Services of the company describes the rationale of how it creates, delivers, and captures value through its products and services offered Information about the company’s management side is also provided that details their names, designation, professional experiences, memberships of boards etc. Through SWOT analysis, the report highlights key internal factors that give the company advantage or disadvantage over its peers along with key external factors prevailing in the industry that may have favorable or unfavorable impact on the company’s operations. The report covers the financial analysis of the company Vital Bio Systems (P) Ltd., which includes the profit & loss a/c for FY 2010, 2009 and 2007 and the balance sheet and the key ratios depicting the key financial figures for FY 2010, 2009, 2008 and 2007. The report also covers the financial analysis of the company Vital Instrumentation (P) Ltd., which includes the profit & loss a/c and the balance sheet and the key ratios depicting the key financial figures for FY 2010, 2009, 2008 and 2007.

Industry Analysis provides top level understanding of the Medical Equipment sector in India with special reference to medical imaging segment. Market size, growth, key segments, growth drivers, import \ export and trends are some of the foremost points covered in the analysis. The competitive landscape identifies key players of the industry drawing comparisons on parameters such financial performance and service offerings. The company is benchmarked against its main competitors’ key financial ratios in the competitive benchmarking chapter.

Published in: Business, Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
441
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Vital bio systems pvt. ltd. - Company Profile

  1. 1. Vital Bio SystemsFebruary 2012
  2. 2. Contents Executive Summary Factsheet Offices & Centres Key Products and Services Key PeopleVital Bio Systems SWOT Analysis Financial Profile Industry Analysis Competitive Landscape Competitive Benchmarking Recent News Appendix 2
  3. 3. Executive SummaryCompany • Vital Bio Systems is a manufacturer of A and has its manufacturing base in Q • The company specializes in the manufacture and distribution of F and RDescriptionKey Products and • It manufactures products such as W, E, R, T, B, N, M, L, U, F, Z, V, DServices • Strength 1 is one of its major strengths, however weakness 1 is one of the key areas of concern • The company can reap significant benefits owing to opportunity 1 while threat 1 may have an adverseSWOT Analysis affect on the strategic initiatives and growth prospects of the organization • The company reported total Income of INR Q mn in FY 20--, registering an increase of a per cent over FY 20--. The company incurred a net loss of INR W in FY 20--, as compared to a net loss of INR G in FY 20-- • Vital Instrumentation (P) Ltd. generated total revenues of INR Z mn in the fiscal year (FY) 20--. It earned a net profit of INR X mn in FY 20-- • The financial profile of Vital Bio Systems (P) Ltd. includes the profit & loss a/c for FY 20--, 20-- and 20-- andFinancial Profile the balance sheet and the key ratios depicting the key financial figures for FY 20--, 20--, 20-- and 20-- that informs about the financial health and capacity to run its operations • The financial profile of Vital Instrumentation (P) Ltd. includes the profit & loss a/c and the balance sheet and the key ratios depicting the key financial figures for FY 20--, 20--, 20-- and 20-- that informs about the financial health and capacity to run its operations • Medical Equipments market is estimated at INR W bn in FY 20-- and expected to grow at a CAGR of x per cent to reach INR X bn in FY 20-- • The Medical Equipments market is classified into segments such as X, Y, Z, PIndustry Analysis • Imaging and Diagnostic Device market in India is estimated at INR C bn in FY 20-- and is expected to grow at a CAGR of c per cent to reach INR D bn in FY 20-- • The major imaging devices are R, S, T, U, VCompetitive • Key competitors of the company can be enlisted as: Competitor 1 and Competitor 2Landscape 3
  4. 4. FactsheetBasic Information Brief DescriptionIndustry -- • Vital Bio Systems (Vital) is a E and B of I and has itsCorporate Address -- manufacturing base in L • Vital is an G company. It specializes in the T and U of H and W • Vital Bios Systems consists of W companies: LETel No. -- MP -- SAFax No. -- --Website -- • The company collaborated with E to use their T in the B. It hasYear Founded -- also collaborated with R for V, M and AYear of Incorporation: -- • The client list of Vital include Z, X, V and D over Q, T, Y, U, S, J, etcVital Bio Systems (P) Ltd.Vital Instrumentation (P) • Vital also has U and has Y in PLtd.Ownership --Revenue: --Vital Bio Systems (P) Ltd.Vital Instrumentation (P)Ltd.Fiscal Year End -- Brief HistoryAuditor -- •19--:Key Competitors: -- •19--: •19--:Source: 4
  5. 5. Offices & Distribution Network – India PLE SAM Headquarters Distribution Network Note:Source: Note: 5
  6. 6. Distribution Network – Global MPLE SA Distribution Network Note:Source: 6
  7. 7. Key Products and Services (1/2)The company generates revenue through the following product portfolio: Segments Products / Models -- -- A -- -- -- -- B -- -- -- -- -- -- C -- -- -- -- -- -- -- D -- -- -- -- -- E -- -- -- -- -- -- M -- -- -- -- -- -- N -- -- -- -- -- -- O -- -- -- -- -- --Source: P -- SAMPLE -- -- -- -- -- 7
  8. 8. Key People (1/2)Key People Name Designation Age (years) Date of Appointment -- -- -- -- -- SAMPLE -- -- --Share Holding Pattern (Vital Bio) Share Holding Pattern of (Vital Instrumentation) W Q R b% 100% a% c%Source: Note: 8
  9. 9. Key People (2/2) Shareholders of Vital Bio Shareholders of Vital Instrumentation Name No. of Shares held Name No. of Shares held -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- LE -- -- -- -- SAMP -- -- -- -- -- -- -- -- Ownership Structure Ownership StructureTotal Paid-up Capital INR A Total Paid-up Capital INR BNumber of Shareholders - Number of Shareholders - Source: Note: 9
  10. 10. SWOT Analysis (1/2) Strengths Weakness• Strength 1 •Weakness 1• Strength 2 Internal Factors SAMPLESource: 10
  11. 11. SWOT Analysis (2/2) Opportunities Threats• Opportunity 1 • Threat 1• Opportunity 2 • Threat 2 External Factors SAMPLESource: 11
  12. 12. Financial Profile (Vital Bio) (1/3)Financial Snapshot Profit & Loss Statement Total Income Particulars 2007 2009 2010 Net Profit/LossINR mn Operating Income - - -8 T Q E Non Operating Income - - -6 Total Income - - -42 Operating expenses - - - W Administrative0 - - - Expenses Y R-2 Interest Expenses - - - 20-- 20-- 20-- Other Expenditure - - -Financial Summary Total Expenditure - - -• Analysis point 1 Earning before - - -• Analysis point 2 Interest & Taxes (EBIT)• Analysis point 3 Profit/(Loss) before - - - TaxSource: SAMPLE Profit/(Loss) after Tax Note: - - - 12
  13. 13. Ratio Analysis (Vital Bio) (3/3) Key Ratios Key Ratio Analysis y-o-y Particulars change 2010 2009 2008 2007 • Analysis point 1 (2010-09) Profitability Ratios • Analysis point 2 Operating Margin - - - - - LE Net Margin - - - - - • Analysis point 3 P Profit Before Tax Margin - - - - - Return on Equity - - - - - AM Return on Capital Employed - - - - - • Analysis point 4 Return on Working Capital Return on Assets Return on Fixed AssetsCost Ratios Operating costs - - - - - - - - - - - - - - - - - - - - - - - - - S • Analysis point 5 • Analysis point 6 Administration costs - - - - - Interest costs - - - - - • Analysis point 7Liquidity Ratios - - - - - Current Ratio - - - - - Cash Ratio - - - - -Leverage Ratios - - - - - Debt to Equity Ratio - - - - - Debt to Capital Ratio - - - - - Interest Coverage Ratio - - - - -Efficiency Ratios - - - - - Fixed Asset Turnover - - - - - Asset Turnover - - - - - Current Asset Turnover - - - - - Working Capital Turnover - - - - - Capital Employed Turnover - - - - - Source: Improved Decline Note: 13
  14. 14. Financial Profile (Vital Instrumentation) (1/2)Financial Snapshot Profit & Loss Statement Total Income Particulars 2007 2008 2009 2010 Net Profit/LossINR mn Operating Income - - - -8 A Non Operating - - - -6 Income4 C E Total Income - - - - Operating2 - - - - expenses B F Administrative0 - - - - Expenses D-2 Interest Expenses - - - - 20-- 20-- 20-- Other Expenditure - - - -Financial Summary Total Expenditure - - - - Earning before Interest & Taxes - - - -• Analysis point 1 (EBIT) SAMPLE Profit/(Loss) before Tax Profit/(Loss) after Tax - - - - - - - -Source: Note: 14
  15. 15. Annual Financial Ratios (Vital Bio 1/3) Profitability Ratios 5 10 0 0 2007 2009 2010 2007 2009 2010 -10 -5 -20-10 -30 LE-15 -40 MP 5 0 2007 SA 2009 2010 50 0 2007 -50 2009 2010 -100 -5 -150-10 -200 -250-15 -300Source: 15
  16. 16. Industry AnalysisMedical Equipment Industry – Overview Market Size & Growth (20-- -20--e)• The Medical Equipment market is estimated at INR A bn in FY 20-- and expected to grow at a CAGR of x per cent to reach INR B INR bn bn by FY 20-- 100 G• This market can be classified into segments such as C, D, E and F x% F• Indian medical equipment market imports y per cent of its 80 E medical equipments from countries such as M, N, O, P D 60 C• Major trends observed in the medical equipment market are: B A Trend 1 40 LE Trend 2 Trend 3 20 Trend 4 Trend 5 MP• Some of the key drivers of the medical equipment market are: 0 20-- 20-- 20--e 20--e 20--e 20--e 20--e SA Driver 1 Driver 2 Driver 3 Market Segmentation (FY 20--) Driver 4 Driver 5 a%• Some of the Government initiatives towards the Medical d% equipment market were: M Point 1 N Point 2 O b% P c%Source: 16
  17. 17. Industry AnalysisImaging and Diagnostic Device Market – Overview Market Size & Growth (20-- -20--e)• The Imaging and Diagnostic device market in India is estimated at INR P bn in FY 20-- and is expected to grow at a CAGR of y per INR bn cent to reach INR Q bn by FY 20-- 60 p% Y• Major segments of Imaging devices include: X Segment 1 W 40 V Segment 2 T U S LE Segment 3 20 Segment 4 MP Segment 5• Some of the trends observed in the Imaging Devices market are: 0 20-- 20-- 20--e 20--e 20--e 20--e 20--e SA Trend 1 Trend 2 Import-Export - Major Imaging Devices (20--) Trend 3 Trend 4 INR mn Y H Z 4,000 3,500 3,000 D 2,500 12% 49% 2,000 1,500 1,000 G I M 500 F J L E K 0 Segment 1 Segment 2 Segment 3 Segment 4 Segment 5Source: 17
  18. 18. Competitive Landscape (1/2) Company Name Description Company 1 • -- • -- • -- • -- LE Company 2 • -- • -- • -- • -- SAMPSource: 18
  19. 19. Competitive Landscape (2/2)Competitive ScenarioCompany Name Company A Company B Company C Financial Information (INR mn – FY 2010)Total Revenue - - -Net Profit/(loss) - - - Major Market Segmentation (Medical Equipments)Imaging andDiagnostic Devices:Ultrasound ImagingMRI SystemsMedical X – RayMachines PLEECG MachinesVentilatorsDopplerPulse Oximeter SAMBlood PressureMonitorPatient MonitoringSource: H: High; L: Low; M: Medium Offered Not Offered 19
  20. 20. Competitive Benchmarking (Vital Bio)Key Financial Ratios – FY 2010 (1/2) % Q W 10 K G L • Analysis point 1 5 F • Analysis point 2 0 • Analysis point 3 -5 C H X Y Z % R T 40 D • Analysis point 4 LE B V H 20 • Analysis point 5 0-20 S C MP • Analysis point 6100 % X L U Y O Z P SA50 • Analysis point 7 0 X Y ZSource: 20
  21. 21. Thank you for the attentionVital Bio Systems is a part of Netscribes’ Healthcare Company Profile Series.For more detailed information or customized research requirements please contact:Jitendra PunjabiPhone: +91 33 4064 6215E-Mail: jitendra.punjabi@netscribes.comAbout NetscribesNetscribes is a knowledge-consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment& business research, business & corporate intelligence, content-management services, and knowledge-software services. At its core lies atrue value proposition that draws upon a vast knowledge base. Netscribes is a one-stop shop designed to fulfil clients’ profitability andgrowth objectives.This report is published for general information only. Although high standards have been used in preparing this report, Netscribes (India) Pvt.Ltd. or Netscribes is not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes(India) Pvt. Ltd. and no part may be reproduced without prior written permission. www.netscribes.com 21

×